View source for Reference:WHO WHO - EXPERT COMMITTEE ON SPECIFICATIONS FOR PHARMACEUTICAL PREPARATIONS Forty-fifth report -

{{#set:
|HasDocument=Document:WHO WHO - EXPERT COMMITTEE ON SPECIFICATIONS FOR PHARMACEUTICAL PREPARATIONS Forty-fifth report
|RefScope=G
|RefDocPart=-
|RefLanguage=EN
|RefTagsEN=
|RefTagsOriginal=
|RefTagsFR=
}}

== Document Information ==
{{:Document:WHO WHO - EXPERT COMMITTEE ON SPECIFICATIONS FOR PHARMACEUTICAL PREPARATIONS Forty-fifth report}}

== Reference Details ==
{| class="wikitable" style="width:100%;"
|-
! scope="row" style="width:200px;" | Scope
| G
|-
! scope="row" style="width:200px;" | Document part
| -
|-
! scope="row" style="width:200px;" | Language
| EN
|-
! scope="row" style="width:200px;" | Original entry by
| Florian Adragna
|-
! scope="row" style="width:200px;" | Contributors
| 
|-
! scope="row" style="width:200px;" | Tags (EN)
| 
|-
! scope="row" style="width:200px;" | Tags (original language)
| 
|-
! scope="row" style="width:200px;" | Tags (FR)
| 
|-
! scope="row" | Comment
| GMP documentation principles
|}

== Text ==
Annex 3: WHO good manufacturing practices: main principles for pharmaceutical products
[...]
15. Documentation
[...]
15.6 Where documents require the entry of data, these entries should be clear, legible and indelible. Sufﬁcient space should be provided for such entries.

15.7 Any alteration made to a document should be signed and dated; the alteration should permit the reading of the original information. Where appropriate, the reason for the alteration should be recorded.
[…]
Annex 4: WHO guidelines on good manufacturing practices for blood establishments
[…]
5.2 Document control
[...]
5.2.1 Document management
[…]
When a document has been revised, the document management system should function in such a way as to prevent the inadvertent use of documents that have been superseded.
[...]